Tau Clearance Mechanisms and Their Possible Role in the Pathogenesis of Alzheimer Disease

por Chesser, Adrianne S., Pritchard, Susanne M., Johnson, Gail V. W.
Publicado 2013

The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics

por Pritchard, Susanne M, Dolan, Philip J, Vitkus, Alisa, Johnson, Gail VW
Publicado 2011

Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52

por Jo, Chulman, Gundemir, Soner, Pritchard, Susanne, Jin, Youngnam N., Rahman, Irfan, Johnson, Gail V.W.
Publicado 2014